What's Happening With Waldencast Today?

A SPAC lead by two former L'Oreal executives confirms merger with two growing cosmetic brands in a move that has all of Wall Street talking
Nov. 15, 2021
Unlock Free Stock Insights + 50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

Waldencast Acquisition Corp. (NASDAQ: WALD) today announced details of a merger with vegan makeup brand, Milk Makeup, and specialist skincare startup Obagi. Waldencast, a special purpose acquisition company (SPAC) set up by two former L'Oreal executives, will primarily fund the deal through $345 million that was raised through its IPO.

Founder and CEO Michel Brousset was buoyant in the accompanying press release, where he effused that "partnering with Obagi and Milk Makeup is a major milestone in our ambition to build a best-in-class global multi-brand beauty platform, which will be home for the next generation of high-growth, purpose-driven brands." Now, let's take a closer look at the deal.

Why does this matter to investors?

Following completion of this deal, Waldencast will be valued at approximately $1.2 billion. With a commitment to building a "best-in-class beauty and wellness operating platform," this deal certainly puts the company amongst some of the bigger players in the market. Skincare currently makes up the largest section of the cosmetics industry, accounting for roughly 35% of the entire market share. With this in mind, the acquisition of Obagi has the potential to allow Waldencast to really grow into this space.

Obagi is a scientifically backed, skincare brand with over 30 years of experience in the industry. When asked about the merger, Obagi CEO Jaime Castle explained that Waldencast's ambitions are "aligned with Obagi's purpose, vision, and values, making Waldencast an ideal fit." The merger provides the skincare brand the opportunity to scale at a much faster pace and keen investors will be undoubtedly interested in its potential success.

Similarly, Milk Makeup will look to benefit from the increased capital now available to its operations. The makeup brand prides itself on its values of self-expression and inclusion and currently offers over 300 products through its online platform. As co-founder and Chief Brand Officer Mazdack Rassi put it, "we built Milk Makeup to be a movement as much as a business, and Waldencast is the perfect home for Milk Makeup to achieve its full potential."

So should I buy Waldencast stock?

Waldencast certainly offers high growth potential in an extremely lucrative market. With the concept of ethical investing at an all-time high, the acquisition of sustainable and eco-conscious companies such as these will be more than welcome. The company also boasts experienced leadership with vast insider knowledge of the cosmetics industry.

One thing to keep in mind however is that much will depend on the next few quarters to determine the company's overall viability. Investors might be better off waiting to see some quarterly earnings reports before making the decision to invest.


Are you looking for that right company to kickstart your portfolio? Look no further than MyWallSt, where our shortlist of market-beating stocks will take you to the next level. Don't believe us? Why not get free access today?


Unlock Free Stock Insights +50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

The Home of Successful Investing.

© 2024 MyWallSt Ltd. All rights reserved.


Services

Content

Social

Company

Support

Resources


This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.